Ermenegildo Zegna NV
ZGN
Cars.com
CARS
Lantheus
LNTH
New Fortress Energy
NFE
eBay
EBAY
US Stock MarketDetailed Quotes
SPRO Spero Therapeutics
- 0.871
- -0.003-0.37%
Close Jan 23 16:00 ET
- 0.860
- -0.011-1.24%
Post 16:09 ET
47.47MMarket Cap10.89P/E (TTM)
0.920High0.861Low117.26KVolume0.880Open0.874Pre Close104.11KTurnover0.29%Turnover Ratio2.03P/E (Static)54.52MShares1.89052wk High0.72P/B35.62MFloat Cap0.83052wk Low--Dividend TTM40.90MShs Float23.639Historical High--Div YieldTTM6.73%Amplitude0.680Historical Low0.887Avg Price1Lot Size
Spero Therapeutics Key Stats
EPS
According to the latest financial report of Spero Therapeutics, the latest earnings per share (TTM) for the company is -0.32. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Spero Therapeutics's free cash flow? The latest report shows it as 12.76M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Spero Therapeutics shows that the company's current ratio is 2.68, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Spero Therapeutics, the quick ratio is 2.64, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Spero Therapeutics? The latest ROE figure is -23.49%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Spero Therapeutics, the total asset return on investment (ROA) is -12.03%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Spero Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Spero Therapeutics, the net profit margin is -127.31%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...